OSE Immunotherapeutics provides an update on ongoing proceedings NANTES, France, July 2, 2025, 8 AM – OSE Immunotherapeutics SA (ISIN:…
In alignment with the Presidential Executive Order “Unleashing American Drone Dominance” Golden, CO, June 17, 2025 (GLOBE NEWSWIRE) -- TB2…